Skip to main content
Fig. 7 | Lipids in Health and Disease

Fig. 7

From: 4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters

Fig. 7

Effect of 4-cholesten-3-one and SR9238 on MCF-7 cells determined by MTT assay. Breast cancer cells were treated for 24 and 48 h with 6.25 μM 4-cholesten-3-one alone, 12.5 μM SR9238 alone, or 6.25 μM 4-cholesten-3-one and 12.5 μM SR9238 together. All data were presented as mean ± standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X